GITNUXREPORT 2026

Ambulatory Surgery Centers Statistics

The U.S. ambulatory surgery center market is rapidly expanding due to increasing procedures and Medicare support.

Alexander Schmidt

Research Analyst specializing in technology and digital transformation trends.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Statistic 1

There were 5,808 Medicare-certified ASCs in the U.S. as of 2022.

Statistic 2

ASCs performed over 10.9 million procedures in 2021.

Statistic 3

Number of ASCs grew by 4% from 2020 to 2023.

Statistic 4

75% of ASCs are single-specialty facilities.

Statistic 5

ASCs account for 54% of all outpatient surgeries.

Statistic 6

Over 6,000 ASCs operating in the U.S. in 2023.

Statistic 7

Medicare ASC procedures increased 12% in 2022.

Statistic 8

Average ASC performs 2,500 procedures annually.

Statistic 9

Multispecialty ASCs make up 25% of total facilities.

Statistic 10

ASC volume grew 15% post-pandemic in 2022.

Statistic 11

1,200 new ASCs opened between 2018-2023.

Statistic 12

ASCs in California number over 600.

Statistic 13

National ASC procedure volume hit 11.5 million in 2022.

Statistic 14

40% of ASCs located in suburban areas.

Statistic 15

ASC case volume per facility averaged 3,000 in 2023.

Statistic 16

Florida has the most ASCs at 700+.

Statistic 17

ASC utilization rate reached 85% in 2023.

Statistic 18

Single-specialty ASCs perform 70% of procedures.

Statistic 19

Total U.S. ASC beds exceed 50,000.

Statistic 20

ASC procedure growth 8% YoY in ophthalmology centers.

Statistic 21

20% increase in ASC OR rooms since 2019.

Statistic 22

Texas ASCs total 550 facilities.

Statistic 23

Average ASC staff size is 45 FTEs.

Statistic 24

ASCs handled 23% of all Medicare surgeries in 2022.

Statistic 25

New York has 400 ASCs.

Statistic 26

ASC volume per capita highest in Sunbelt states.

Statistic 27

65% of ASCs physician-owned.

Statistic 28

ASC procedures topped 12 million in 2023.

Statistic 29

Average ASC revenue $15 million annually.

Statistic 30

ASC net margins averaged 28% in 2022.

Statistic 31

Medicare reimbursement for ASCs up 3.2% in 2024.

Statistic 32

Average ASC EBITDA 25-30% of revenue.

Statistic 33

ASC collection rates at 98% for commercial payers.

Statistic 34

Supply costs 20% of ASC total expenses.

Statistic 35

ASC case revenue averaged $2,500 in 2023.

Statistic 36

15% of ASCs reported losses in 2020 due to COVID.

Statistic 37

Private equity-backed ASCs saw 35% revenue growth.

Statistic 38

ASC labor costs rose 7% in 2023.

Statistic 39

Average ASC valuation multiple 8x EBITDA.

Statistic 40

Medicare ASC payments totaled $7.5 billion in 2022.

Statistic 41

ASC payer mix: 40% Medicare, 30% commercial.

Statistic 42

Operating expenses 60% of ASC revenues.

Statistic 43

ASC cash collections up 10% YoY 2023.

Statistic 44

Single-specialty ASCs average $20M revenue.

Statistic 45

ASC bad debt averaged 2.5% of revenue.

Statistic 46

Reimbursement per procedure $1,800 Medicare average.

Statistic 47

ASC profit margins highest in ortho at 32%.

Statistic 48

Total ASC industry revenue $38 billion 2023.

Statistic 49

Staffing costs 35% of ASC budgets.

Statistic 50

ASC AR days averaged 35 in 2023.

Statistic 51

Commercial payer reimbursements 150% of Medicare.

Statistic 52

ASC capex investments $2 billion annually.

Statistic 53

Multispecialty ASC revenue $25M average.

Statistic 54

Denial rates for ASC claims 5%.

Statistic 55

ASC ROI on expansions 18% annually.

Statistic 56

45% of ASC revenue from procedures under 30 min.

Statistic 57

ASCs saw 22% revenue growth 2021-2023.

Statistic 58

The U.S. ambulatory surgery center (ASC) market was valued at $28.3 billion in 2022.

Statistic 59

ASC market is projected to grow at a CAGR of 7.2% from 2023 to 2030.

Statistic 60

Global ASC market expected to reach $108.8 billion by 2030.

Statistic 61

U.S. ASC industry revenue reached $32 billion in 2023.

Statistic 62

ASC market growth driven by 4.5% annual increase in procedures.

Statistic 63

ASC sector saw 8% YoY growth in 2022 due to Medicare expansions.

Statistic 64

Projected ASC market size $45 billion by 2028 in North America.

Statistic 65

Outpatient surgery market CAGR of 6.8% through 2027.

Statistic 66

ASC revenues grew 12% in 2021 post-COVID recovery.

Statistic 67

U.S. ASC market share of outpatient surgeries at 55% in 2023.

Statistic 68

ASC industry expected to add $10 billion in revenue by 2025.

Statistic 69

CAGR of 5.9% for ASCs from 2022-2029 globally.

Statistic 70

U.S. ASC market valued at $25.4 billion in 2021.

Statistic 71

Growth rate of 7.5% in ASC procedures annually.

Statistic 72

ASC market to hit $40.2 billion by 2032.

Statistic 73

9.1% CAGR projected for ASCs in Europe through 2028.

Statistic 74

U.S. ASC revenue growth of 15% in Q4 2023.

Statistic 75

Outpatient ASC market expansion at 6.4% CAGR.

Statistic 76

ASC sector market cap increased 20% since 2020.

Statistic 77

Projected 8.2% growth in ASC investments by 2027.

Statistic 78

U.S. ASC market CAGR 7.0% from 2023-2031.

Statistic 79

Global ASC growth fueled by 10% rise in seniors.

Statistic 80

ASC market revenue $29.5 billion in 2023 estimate.

Statistic 81

6.7% annual growth in ASC facility expansions.

Statistic 82

U.S. ASCs captured 60% outpatient market by 2024.

Statistic 83

CAGR 7.8% for ASC tech integration market.

Statistic 84

ASC revenue per case up 5% YoY in 2023.

Statistic 85

Global ASC market to grow 9% by 2026.

Statistic 86

U.S. ASC industry growth 11% in 2022.

Statistic 87

Projected $50 billion U.S. ASC market by 2030.

Statistic 88

75% of ASC patients are 65+ years old.

Statistic 89

ASC complication rates under 2%.

Statistic 90

90% same-day discharge rate in ASCs.

Statistic 91

Average ASC patient age 55 years.

Statistic 92

Women comprise 60% of ASC patients.

Statistic 93

Pain procedures 25% of ASC caseload.

Statistic 94

ASC readmission rates 1.5% vs 4% hospitals.

Statistic 95

Ophthalmology 30% of ASC procedures.

Statistic 96

40% ASC patients have commercial insurance.

Statistic 97

Infection rates in ASCs 0.5%.

Statistic 98

Gastro procedures 22% of ASC volume.

Statistic 99

Patient satisfaction scores 95% in ASCs.

Statistic 100

Orthopedic procedures up 20% in ASCs.

Statistic 101

65+ patients 50% of Medicare ASC cases.

Statistic 102

Average procedure time 45 minutes in ASCs.

Statistic 103

Urology ASC cases 15% of total.

Statistic 104

ASC mortality rate 0.05%.

Statistic 105

ENT procedures 10% ASC share.

Statistic 106

85% ASC patients report no post-op pain.

Statistic 107

Plastic surgery 8% of ASC procedures.

Statistic 108

BMI average 28 for ASC patients.

Statistic 109

Spine procedures 12% growth in ASCs.

Statistic 110

70% urban ASC patient origin.

Statistic 111

Cataract surgery 40% of eye ASC cases.

Statistic 112

ASC patient no-shows 5%.

Statistic 113

Colonoscopy 60% ASC GI volume.

Statistic 114

92% would recommend ASC to others.

Statistic 115

Knee arthroscopy 25% ortho ASC cases.

Statistic 116

Comorbidities in 30% ASC patients.

Statistic 117

Podiatry procedures 7% ASC total.

Statistic 118

CMS added 20 procedures to ASC list in 2024.

Statistic 119

40% of ASCs accredited by AAAHC.

Statistic 120

Stark Law waivers issued for 500+ ASCs.

Statistic 121

Medicare ASC payment update 2.6% for 2023.

Statistic 122

85% compliance rate with ASC quality reporting.

Statistic 123

No Surprises Act impacts 10% ASC billing.

Statistic 124

ASC Conditions for Coverage met by 95% facilities.

Statistic 125

267 procedures on Medicare ASC-covered list 2024.

Statistic 126

Joint Commission accredits 30% ASCs.

Statistic 127

Telehealth flexibilities extended to 60% ASCs.

Statistic 128

ASC QPP participation 92%.

Statistic 129

HIPAA compliance audits on 15% ASCs annually.

Statistic 130

Site-neutral payment policies affect 20% procedures.

Statistic 131

50 states license ASCs.

Statistic 132

MIPS scores average 85 for ASCs.

Statistic 133

COVID waivers saved ASCs $1.2B.

Statistic 134

ASC penalty rates under 1% for quality.

Statistic 135

75% ASCs use EHR for regulatory compliance.

Statistic 136

Prior auth denials down 12% post-No Surprises.

Statistic 137

ASC transparency rules cover 100% pricing data.

Statistic 138

22 new CPT codes for ASCs in 2023.

Statistic 139

Infection control citations 2% ASCs.

Statistic 140

MAC audits on 10% ASC claims.

Statistic 141

Value-based purchasing pilots in 200 ASCs.

Statistic 142

95% ASCs meet EMTALA requirements.

Statistic 143

Stark self-referral reviews 5% ASCs.

Statistic 144

ASC opioid prescribing rules cover 80% pain cases.

1/144

Sources

Trusted by 500+ publications

+497

As the healthcare landscape shifts dramatically toward outpatient care, the ambulatory surgery center industry is experiencing explosive growth, with a market value hitting $28.3 billion and projected to surpass $100 billion globally by 2030.

Key Takeaways

The U.S. ambulatory surgery center (ASC) market was valued at $28.3 billion in 2022.
ASC market is projected to grow at a CAGR of 7.2% from 2023 to 2030.
Global ASC market expected to reach $108.8 billion by 2030.
There were 5,808 Medicare-certified ASCs in the U.S. as of 2022.
ASCs performed over 10.9 million procedures in 2021.
Number of ASCs grew by 4% from 2020 to 2023.
Average ASC revenue $15 million annually.
ASC net margins averaged 28% in 2022.
Medicare reimbursement for ASCs up 3.2% in 2024.
75% of ASC patients are 65+ years old.
ASC complication rates under 2%.
90% same-day discharge rate in ASCs.
CMS added 20 procedures to ASC list in 2024.
40% of ASCs accredited by AAAHC.
Stark Law waivers issued for 500+ ASCs.

The U.S. ambulatory surgery center market is rapidly expanding due to increasing procedures and Medicare support.

Facility Volume

There were 5,808 Medicare-certified ASCs in the U.S. as of 2022.
ASCs performed over 10.9 million procedures in 2021.
Number of ASCs grew by 4% from 2020 to 2023.
75% of ASCs are single-specialty facilities.
ASCs account for 54% of all outpatient surgeries.
Over 6,000 ASCs operating in the U.S. in 2023.
Medicare ASC procedures increased 12% in 2022.
Average ASC performs 2,500 procedures annually.
Multispecialty ASCs make up 25% of total facilities.
ASC volume grew 15% post-pandemic in 2022.
1,200 new ASCs opened between 2018-2023.
ASCs in California number over 600.
National ASC procedure volume hit 11.5 million in 2022.
40% of ASCs located in suburban areas.
ASC case volume per facility averaged 3,000 in 2023.
Florida has the most ASCs at 700+.
ASC utilization rate reached 85% in 2023.
Single-specialty ASCs perform 70% of procedures.
Total U.S. ASC beds exceed 50,000.
ASC procedure growth 8% YoY in ophthalmology centers.
20% increase in ASC OR rooms since 2019.
Texas ASCs total 550 facilities.
Average ASC staff size is 45 FTEs.
ASCs handled 23% of all Medicare surgeries in 2022.
New York has 400 ASCs.
ASC volume per capita highest in Sunbelt states.
65% of ASCs physician-owned.
ASC procedures topped 12 million in 2023.

Facility Volume Interpretation

Ambulatory Surgery Centers are now the undisputed heavyweight champions of outpatient care, having surgically transformed the landscape by performing over 12 million procedures in 2023 from their sprawling network of more than 6,000 facilities, which are busily operating at near capacity while continuing a remarkable expansion driven largely by physician ownership.

Financial Performance

Average ASC revenue $15 million annually.
ASC net margins averaged 28% in 2022.
Medicare reimbursement for ASCs up 3.2% in 2024.
Average ASC EBITDA 25-30% of revenue.
ASC collection rates at 98% for commercial payers.
Supply costs 20% of ASC total expenses.
ASC case revenue averaged $2,500 in 2023.
15% of ASCs reported losses in 2020 due to COVID.
Private equity-backed ASCs saw 35% revenue growth.
ASC labor costs rose 7% in 2023.
Average ASC valuation multiple 8x EBITDA.
Medicare ASC payments totaled $7.5 billion in 2022.
ASC payer mix: 40% Medicare, 30% commercial.
Operating expenses 60% of ASC revenues.
ASC cash collections up 10% YoY 2023.
Single-specialty ASCs average $20M revenue.
ASC bad debt averaged 2.5% of revenue.
Reimbursement per procedure $1,800 Medicare average.
ASC profit margins highest in ortho at 32%.
Total ASC industry revenue $38 billion 2023.
Staffing costs 35% of ASC budgets.
ASC AR days averaged 35 in 2023.
Commercial payer reimbursements 150% of Medicare.
ASC capex investments $2 billion annually.
Multispecialty ASC revenue $25M average.
Denial rates for ASC claims 5%.
ASC ROI on expansions 18% annually.
45% of ASC revenue from procedures under 30 min.
ASCs saw 22% revenue growth 2021-2023.

Financial Performance Interpretation

The average ASC is a surprisingly efficient cash engine, turning a high-margin $15 million revenue stream while deftly managing costs, yet it nervously eyes rising labor expenses and an ever-shifting reimbursement landscape where a single Medicare rate change can mean the difference between a healthy 28% net profit and joining the unfortunate 15% that reported losses.

Market Growth

The U.S. ambulatory surgery center (ASC) market was valued at $28.3 billion in 2022.
ASC market is projected to grow at a CAGR of 7.2% from 2023 to 2030.
Global ASC market expected to reach $108.8 billion by 2030.
U.S. ASC industry revenue reached $32 billion in 2023.
ASC market growth driven by 4.5% annual increase in procedures.
ASC sector saw 8% YoY growth in 2022 due to Medicare expansions.
Projected ASC market size $45 billion by 2028 in North America.
Outpatient surgery market CAGR of 6.8% through 2027.
ASC revenues grew 12% in 2021 post-COVID recovery.
U.S. ASC market share of outpatient surgeries at 55% in 2023.
ASC industry expected to add $10 billion in revenue by 2025.
CAGR of 5.9% for ASCs from 2022-2029 globally.
U.S. ASC market valued at $25.4 billion in 2021.
Growth rate of 7.5% in ASC procedures annually.
ASC market to hit $40.2 billion by 2032.
9.1% CAGR projected for ASCs in Europe through 2028.
U.S. ASC revenue growth of 15% in Q4 2023.
Outpatient ASC market expansion at 6.4% CAGR.
ASC sector market cap increased 20% since 2020.
Projected 8.2% growth in ASC investments by 2027.
U.S. ASC market CAGR 7.0% from 2023-2031.
Global ASC growth fueled by 10% rise in seniors.
ASC market revenue $29.5 billion in 2023 estimate.
6.7% annual growth in ASC facility expansions.
U.S. ASCs captured 60% outpatient market by 2024.
CAGR 7.8% for ASC tech integration market.
ASC revenue per case up 5% YoY in 2023.
Global ASC market to grow 9% by 2026.
U.S. ASC industry growth 11% in 2022.
Projected $50 billion U.S. ASC market by 2030.

Market Growth Interpretation

The numbers paint a clear, lucrative picture: ambulatory surgery centers are growing at a healthy clip not just because it's profitable, but because patients and payers are decisively voting with their feet for efficient, high-quality outpatient care.

Patient Data

75% of ASC patients are 65+ years old.
ASC complication rates under 2%.
90% same-day discharge rate in ASCs.
Average ASC patient age 55 years.
Women comprise 60% of ASC patients.
Pain procedures 25% of ASC caseload.
ASC readmission rates 1.5% vs 4% hospitals.
Ophthalmology 30% of ASC procedures.
40% ASC patients have commercial insurance.
Infection rates in ASCs 0.5%.
Gastro procedures 22% of ASC volume.
Patient satisfaction scores 95% in ASCs.
Orthopedic procedures up 20% in ASCs.
65+ patients 50% of Medicare ASC cases.
Average procedure time 45 minutes in ASCs.
Urology ASC cases 15% of total.
ASC mortality rate 0.05%.
ENT procedures 10% ASC share.
85% ASC patients report no post-op pain.
Plastic surgery 8% of ASC procedures.
BMI average 28 for ASC patients.
Spine procedures 12% growth in ASCs.
70% urban ASC patient origin.
Cataract surgery 40% of eye ASC cases.
ASC patient no-shows 5%.
Colonoscopy 60% ASC GI volume.
92% would recommend ASC to others.
Knee arthroscopy 25% ortho ASC cases.
Comorbidities in 30% ASC patients.
Podiatry procedures 7% ASC total.

Patient Data Interpretation

The statistics paint a picture of the modern Ambulatory Surgery Center as a remarkably efficient, safe, and patient-pleasing machine, expertly fine-tuned for the brisk, predictable care of an aging but generally healthy population that is very happy to go home the same day.

Regulatory Policy

CMS added 20 procedures to ASC list in 2024.
40% of ASCs accredited by AAAHC.
Stark Law waivers issued for 500+ ASCs.
Medicare ASC payment update 2.6% for 2023.
85% compliance rate with ASC quality reporting.
No Surprises Act impacts 10% ASC billing.
ASC Conditions for Coverage met by 95% facilities.
267 procedures on Medicare ASC-covered list 2024.
Joint Commission accredits 30% ASCs.
Telehealth flexibilities extended to 60% ASCs.
ASC QPP participation 92%.
HIPAA compliance audits on 15% ASCs annually.
Site-neutral payment policies affect 20% procedures.
50 states license ASCs.
MIPS scores average 85 for ASCs.
COVID waivers saved ASCs $1.2B.
ASC penalty rates under 1% for quality.
75% ASCs use EHR for regulatory compliance.
Prior auth denials down 12% post-No Surprises.
ASC transparency rules cover 100% pricing data.
22 new CPT codes for ASCs in 2023.
Infection control citations 2% ASCs.
MAC audits on 10% ASC claims.
Value-based purchasing pilots in 200 ASCs.
95% ASCs meet EMTALA requirements.
Stark self-referral reviews 5% ASCs.
ASC opioid prescribing rules cover 80% pain cases.

Regulatory Policy Interpretation

In 2024, the ambulatory surgery center landscape is one of cautious optimism, where incremental payment bumps and growing procedural lists are cautiously balanced by a thicket of compliance audits, accreditation hurdles, and regulatory fine print that keeps administrators on their toes.

Sources & References

Logos provided by Logo.dev